NAGE

Niagen Bioscience

82 hedge funds and large institutions have $49.9M invested in Niagen Bioscience in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 30 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 8382 (-1)

34% less capital invested

Capital invested by funds: $75.8M → $49.9M (-$25.9M)

40% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 30

Holders
82
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$478K
Puts
$255K
Net Calls
Net Calls Change

Top Sellers

1 -$1.55M
2 -$1.4M
3 -$1M
4
Millennium Management
Millennium Management
New York
-$845K
5
Goldman Sachs
Goldman Sachs
New York
-$186K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10M
2
$7.76M
3
$6.84M
4
$3.52M
5
$3.18M
6
$2.29M
7
$2.27M
8
$1.95M
9
$1.88M
10
$1.05M
11
$1.03M
12
$1.02M
13
$874K
14
$511K
15
$505K
16
$358K
17
$314K
18
$268K
19
$240K
20
$210K
21
$204K
22
$203K
23
$193K
24
$182K
25
$162K